Literature DB >> 17887916

Hypoxia and heme oxygenases: oxygen sensing and regulation of expression.

Shigeki Shibahara1, Feng Han, Bin Li, Kazuhisa Takeda.   

Abstract

Heme is an essential molecule for life, as it is involved in sensing and using oxygen. Heme must be synthesized and degraded within an individual nucleated cell. Physiologic heme degradation is catalyzed by two functional isozymes of heme oxygenase, heme oxygenase-1 (HO-1) and HO-2, yielding carbon monoxide, iron, and biliverdin, an immediate precursor to bilirubin. HO-1 is an inducible enzyme, but the expression level of HO-2 is maintained in a narrow range. Characteristically, human HO-1 contains no Cys residue, whereas human HO-2 contains three Cys residues, each of which might be involved in heme binding. These features suggest separate physiologic roles of HO-1 and HO-2. Recent studies have shown that the expression levels of HO-1 and HO-2 are reduced under hypoxia, depending on the cell types. Moreover, we have proposed HO-2 as a potential O(2) sensor, because HO-2-deficient mice show hypoxemia and a blunted hypoxic ventilatory response with normal hypercapnic ventilatory response. HO-2-deficient mice also show hypertrophy of the pulmonary venous myocardium and enlargement of the carotid body. These morphometric changes are attributable to chronic hypoxemia. Here, we update the understanding of the regulation of HO-1 and HO-2 expression and summarize the regulatory role of HO-2 in the intercellular communication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17887916     DOI: 10.1089/ars.2007.1784

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  16 in total

Review 1.  Control of intracellular heme levels: heme transporters and heme oxygenases.

Authors:  Anwar A Khan; John G Quigley
Journal:  Biochim Biophys Acta       Date:  2011-01-14

2.  Possible role of heme oxygenase-1 and prostaglandins in the pathogenesis of cerebral malaria: heme oxygenase-1 induction by prostaglandin D(2) and metabolite by a human astrocyte cell line.

Authors:  Jiraporn Kuesap; Kesara Na-Bangchang
Journal:  Korean J Parasitol       Date:  2010-03-17       Impact factor: 1.341

Review 3.  Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease.

Authors:  Danielle Morse; Ling Lin; Augustine M K Choi; Stefan W Ryter
Journal:  Free Radic Biol Med       Date:  2009-04-09       Impact factor: 7.376

4.  Mitochondria-targeted heme oxygenase-1 decreases oxidative stress in renal epithelial cells.

Authors:  Subhashini Bolisetty; Amie Traylor; Abolfazl Zarjou; Michelle S Johnson; Gloria A Benavides; Karina Ricart; Ravindra Boddu; Ray D Moore; Aimee Landar; Stephen Barnes; Victor Darley-Usmar; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-29

Review 5.  Insights on the mechanisms of action of ozone in the medical therapy against COVID-19.

Authors:  Salvatore Chirumbolo; Luigi Valdenassi; Vincenzo Simonetti; Dario Bertossi; Giovanni Ricevuti; Marianno Franzini; Sergio Pandolfi
Journal:  Int Immunopharmacol       Date:  2021-05-11       Impact factor: 5.714

6.  Heme oxygenase-1 plays a pro-life role in experimental brain stem death via nitric oxide synthase I/protein kinase G signaling at rostral ventrolateral medulla.

Authors:  Kuang-Yu Dai; Samuel Hh Chan; Alice Yw Chang
Journal:  J Biomed Sci       Date:  2010-09-07       Impact factor: 8.410

7.  Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.

Authors:  Iman M Ahmad; Alicia J Dafferner; Kelly A O'Connell; Kamiya Mehla; Bradley E Britigan; Michael A Hollingsworth; Maher Y Abdalla
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

8.  Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage.

Authors:  Shifeng Zhao; Xueqiao Wang; Xiaoqing Zheng; Xiu Liang; Zhigang Wang; Juanlian Zhang; Xudong Zhao; Shougang Zhuang; Qiuhui Pan; Fenyong Sun; Wenjun Shang; Jonathan Barasch; Andong Qiu
Journal:  Free Radic Biol Med       Date:  2021-07-21       Impact factor: 8.101

9.  Changes of hypoxia-inducible factor-1 signaling and the effect of cilostazol in chronic cerebral ischemia.

Authors:  Han Chen; Aixuan Wei; Jinting He; Ming Yu; Jing Mang; Zhongxin Xu
Journal:  Neural Regen Res       Date:  2013-07-05       Impact factor: 5.135

Review 10.  Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.

Authors:  Francesca Vinchi; Emanuela Tolosano
Journal:  Oxid Med Cell Longev       Date:  2013-05-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.